ATRC
AtriCure, Inc.Company with tickers: ATRC
CIK
1323885
CUSIP
04963C209
Shares Outstanding
50,640,970
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $123,620,000 | USD | 2025-03-31 | 10-Q | 2026-05-06 |
| Cost of Revenue | $30,992,000 | USD | 2025-03-31 | 10-Q | 2026-05-06 |
| Gross Profit | $92,628,000 | USD | 2025-03-31 | 10-Q | 2026-05-06 |
| Operating Expenses | $98,582,000 | USD | 2025-03-31 | 10-Q | 2026-05-06 |
| Research & Development | $22,528,000 | USD | 2025-03-31 | 10-Q | 2026-05-06 |
| Operating Income | $-5,954,000 | USD | 2025-03-31 | 10-Q | 2026-05-06 |
| Net Income | $-6,747,000 | USD | 2025-03-31 | 10-Q | 2026-05-06 |
| EPS (Basic) | $-0.14 | USD/shares | 2025-03-31 | 10-Q | 2026-05-06 |
| EPS (Diluted) | $-0.14 | USD/shares | 2025-03-31 | 10-Q | 2026-05-06 |